Publication & Citation Trends
Most Cited Works
Publications
73 total
Eligibility varies among the 4 sodium-glucose cotransporter-2 inhibitor cardiovascular outcomes trials: implications for the general type 2 diabetes US population.
Cited by 33
OpenAlex
Comparison of costs and outcomes of dapagliflozin with other glucose-lowering therapy classes added to metformin using a short-term cost-effectiveness model in the US setting
Cited by 26
OpenAlex
Generalizability of glucagon-like peptide-1 receptor agonist cardiovascular outcome trials enrollment criteria to the US type 2 diabetes population.
Cited by 20
OpenAlex
Comparing Medication Adherence and Persistence Among Patients with Type 2 Diabetes Using Sodium-Glucose Cotransporter 2 Inhibitors or Sulfonylureas. OA
Cited by 23
OpenAlex
An Evaluation of Mpowerment on Individual-Level HIV Risk Behavior, Testing, and Psychosocial Factors Among Young MSM of Color: The Monitoring and Evaluation of MP (MEM) Project
Cited by 20
OpenAlex
Understanding CKD among patients with T2DM: prevalence, temporal trends, and treatment patterns—NHANES 2007–2012 PDF
Cited by 212
OpenAlex
Research Topics
Diabetes Treatment and Management
(27)
Diabetes Management and Research
(14)
Lung Cancer Treatments and Mutations
(12)
Cancer Immunotherapy and Biomarkers
(10)
Lung Cancer Diagnosis and Treatment
(6)
Frequent Co-Authors
Affiliations
Bristol-Myers Squibb (Germany)
Providence College
Stephen F. Austin State University
Bristol-Myers Squibb (United States)
Ipsos (United States)